Israel - hebraisk - Ministry of Health

eliezer linevitz ltd. - ivermectin - פסטה - ivermectin 18.7 mg/g

Israel - hebraisk - Ministry of Health

comex ltd - ivermectin - תמיסה להזרקה - ivermectin 10 mg/ml

Israel - hebraisk - Ministry of Health

m.p.vet ltd - marbofloxacin - תמיסה להזרקה - marbofloxacin 100 mg / 1 ml

Israel - hebraisk - Ministry of Health

abic marketing ltd, israel - efavirenz; emtricitabine; tenofovir disoproxil as fumarate - טבליות מצופות פילם - efavirenz 600 mg; emtricitabine 200 mg; tenofovir disoproxil as fumarate 245 mg - emtricitabine, tenofovir disoproxil and efavirenz

Israel - hebraisk - Ministry of Health

romat ltd - marbofloxacin - תמיסה להזרקה - marbofloxacin 100 mg / 1 ml

Israel - hebraisk - Ministry of Health

gsk consumer healthcare, israel ltd - calcium carbonate; calcium lactate gluconate; colecalciferol - טבליה תוססת - calcium lactate gluconate 1358 mg; calcium carbonate 1050 mg; colecalciferol 4 mg - calcium lactate gluconate - calcium lactate gluconate - calcium and vitamin d supplement. calcium helps in the maintenance of bones and teeth. vitamin d helps in the absorption and use of calcium.

Israel - hebraisk - Ministry of Health

sanofi - aventis israel ltd - cefotaxime as sodium 1 g - powder for solution for inj/inf - cefotaxime - severe infections caused by cefotaxime - sensitive pathogens : infections of the respiratory tract of the kidneys and urinary tract of the skin and soft tissues of the bones and joints of the genital organs including gonorrhoea and of the abdominal region. sepsis endocarditis meningitis. for preoperative prophylaxis in patients who are at increased risk from infection. for the prophylaxis of infections in patients with reduced resistance.

Israel - hebraisk - Ministry of Health

pharmalogic ltd - ceftriaxone as sodium - אבקה להמסה להזרקה\אינפוזיה - ceftriaxone as sodium 1 g/vial - ceftriaxone - ceftriaxone - treatment of infections caused by pathogens sensitive to ceftriaxone, e.g.: sepsis, meningitis, abdominal infections (peritonitis, infection of the biliary and gastrointestinal tract), infections of the bones, loints, soft tissue, skin and of wounds, infections in patients with impaired defense mechanisms, renal and urinary tract infections, respiratory tract infections, particularly pneumonia, and ear, nose and throat infections, genital infections including gonorrhea. perioperative prophylaxis of infections.

Israel - hebraisk - Ministry of Health

sanofi - aventis israel ltd - ofloxacin 2 mg/ml - solution for infusion - ofloxacin - infections of kidney, urinarty tract, genital organs, respiratory tract, chronic and recurrent ear, nose and throat, skin and soft tissues, bones and joints, bacterial enteritis, abdominal cavity, including pelvis minor and septicemia caused by ofloxacin sensitive microorganisms. prevention of infections in patients with a signifcant reduction of resistance to infections,

Israel - hebraisk - Ministry of Health

abic ltd. - ofloxacin - טבליה - ofloxacin 200 mg - ofloxacin - ofloxacin - bacterial infections due to ofloxacin-susceptible microorganisms, such as:- acute, chronic, or recurrent lower respiratory tract infections (bronchitis) pneumonia (not for the treatment of first choice in pnemonia caused by pneumococci). - chronic and recurrent infections of the ear, nose, and throat. ofloxacin is in general not indicated for the treatment of acute tonsillitis caused by betahaemolytic streptococci. - infections of soft tissues and skin. - infections of the bones and joints. - abdominal infections including infections in the pelvis minor and bacterial enteritis. - infections of the kidney, urinary tract, and genital organs, gonorrhoea.prevention of infections due to ofloxacin-susceptible pathogens in patients with a significant reduction in resistance to infections (e.g. in neutropenic state).